Showing results (1-10 of 230) with videos related to
Sort By:
Pageof 23
Expert Review of Neurotherapeutics|March 19, 2008
DNA-based vaccines: the future of multiple sclerosis therapy?Olaf Stüve, Petra D Cravens, Todd N EagarVaccine|June 22, 2010
Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's diseaseBao-Xi Qu, Doris Lambracht-Washington, Min Fu, et al.JAMA|October 29, 2009
DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse modelDoris Lambracht-Washington, Bao-Xi Qu, Min Fu, et al.Journal of the Neurological Sciences|August 21, 2007
Prion proteins: physiological functions and role in neurological disordersWei Hu, Bernd Kieseier, Elliot Frohman, et al.Journal of Neuroimmunology|October 6, 2012
A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer diseaseDoris Lambracht-Washington, Bao-xi Qu, Min Fu, et al.Cellular and Molecular Neurobiology|June 1, 2011
DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferationDoris Lambracht-Washington, Bao-Xi Qu, Min Fu, et al.Autonomic Neuroscience : Basic & Clinical|August 18, 2009
Direct and consensual murine pupillary reflex metrics: establishing normative valuesRehana Z Hussain, Steven C Hopkins, Elliot M Frohman, et al.Journal of Neuroimmunology|September 18, 2014
Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillanceCyd Castro-Rojas, Krystin Deason, Rehana Z Hussain, et al.Journal of Neuroimmunology|October 6, 2014
Immune surveillance of the central nervous system in multiple sclerosis--relevance for therapy and experimental modelsRehana Z Hussain, Liat Hayardeny, Petra C Cravens, et al.Journal of the Neurological Sciences|January 29, 2010
Knowns and unknowns in the future of multiple sclerosis treatmentOlaf StüvePageof 23